학술논문
Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany
Document Type
Article
Author
Source
In: Neurology: Neuroimmunology and NeuroInflammation . (Neurology: Neuroimmunology and NeuroInflammation, 1 May 2019, 6(3))
Subject
Language
English
ISSN
23327812